These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35588988)

  • 21. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies.
    Karch CM; Jeng AT; Goate AM
    J Biol Chem; 2012 Dec; 287(51):42751-62. PubMed ID: 23105105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
    Gratuze M; Josset N; Petry FR; Pflieger M; Eyoum Jong L; Truchetti G; Poitras I; Julien J; Bezeau F; Morin F; Samadi P; Cicchetti F; Bretzner F; Planel E
    Brain Res; 2019 May; 1711():106-114. PubMed ID: 30641037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
    Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
    Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
    Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
    Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.
    Ferrer I; Andrés-Benito P; Ausín K; Cartas-Cejudo P; Lachén-Montes M; Del Rio JA; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
    J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
    Komuro Y; Xu G; Bhaskar K; Lamb BT
    Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
    Blard O; Feuillette S; Bou J; Chaumette B; Frébourg T; Campion D; Lecourtois M
    Hum Mol Genet; 2007 Mar; 16(5):555-66. PubMed ID: 17309878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.
    Barron MR; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC
    Front Immunol; 2020; 11():293. PubMed ID: 32194553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of Tau on the integrity and function of neurons essential for learning in Drosophila.
    Kosmidis S; Grammenoudi S; Papanikolopoulou K; Skoulakis EM
    J Neurosci; 2010 Jan; 30(2):464-77. PubMed ID: 20071510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxin A modulates the axonal release of pathological tau in hippocampal neurons.
    Panzi C; Surana S; De La-Rocque S; Moretto E; Lazo OM; Schiavo G
    Toxicon; 2023 Jun; 228():107110. PubMed ID: 37037273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human TTBK1, TTBK2 and MARK1 kinase toxicity in
    Fernius J; Starkenberg A; Pokrzywa M; Thor S
    Biol Open; 2017 Jul; 6(7):1013-1023. PubMed ID: 28711868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
    Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
    J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired burrowing is the most prominent behavioral deficit of aging htau mice.
    Geiszler PC; Barron MR; Pardon MC
    Neuroscience; 2016 Aug; 329():98-111. PubMed ID: 27167086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
    Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
    PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.
    Rossi F; Geiszler PC; Meng W; Barron MR; Prior M; Herd-Smith A; Loreto A; Lopez MY; Faas H; Pardon MC; Conforti L
    Behav Brain Res; 2018 Feb; 339():140-152. PubMed ID: 29175372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.
    Levenga J; Krishnamurthy P; Rajamohamedsait H; Wong H; Franke TF; Cain P; Sigurdsson EM; Hoeffer CA
    Acta Neuropathol Commun; 2013 Jul; 1():34. PubMed ID: 24252661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
    Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model.
    Pir GJ; Choudhary B; Mandelkow E; Mandelkow EM
    Mol Neurodegener; 2016 Apr; 11():33. PubMed ID: 27118310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.